EQS Voting Rights Announcement: Marinomed Biotech AG Marinomed Biotech AG: Publication in accordance with Section 135 Para. 2 BörseG with the aim of Europe-wide distribution April 15, 2024 / 4:00 p.m. CET/CEST Publication of a voting rights announcement transmitted by EQS News – a service of EQS Group AG. The issuer/publisher is responsible for the content of the message. ══════════════════════════════════════════════════ ══════════════════════════ Participation report according to §§ 130 to 134 Börseg 2018 Vienna, 15.4.2024 Overview ☐ Message takes place after the expiry of the deadline. 137 BörseG 2018, the suspension of voting rights must be observed if a person violates the obligation to report shareholdings. 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition/sale of shares (voting rights) 3. Person subject to reporting obligation Name: LLB Invest Kapitalanlagegesellschaft mbH Registered office: Vienna Country: Austria 4. Names of shareholders: 5. Date the threshold was reached: April 15 .2024 6. Overall position of the person required to report Percentages of the percentage shares of voting rights, which represent the total number of financial/other sum of voting rights, instruments of voting rights belonging to shares (7.B.1 + 7.A + the (7.A) 7.B.2) 7.B in issuers % Situation on the day of 5.02% 0.00% 5.02% 1 540 530 Threshold touching Situation in the previous report 4.01% 0.00% 4.01% ( if applicable) Details 7. Details about the instruments held on the day the threshold is touched: A: Voting rights belonging to shares ISIN of the shares Number of voting rights Percentage of voting rights Direct Indirect Direct Indirect (§ 130 BörseG (§ 133 BörseG (§ 130 BörseG (Section 133 BörseG 2018) 2018) 2018) 2018) ATMARIONOMED6 77 374 0 5.02% 0.00% Subtotal A 77 374 5.02% B 1: Financial instruments / other instruments in accordance with Section 131 Paragraph 1 Z 1 BörseG 2018 Art of the expiry date Exercise period Number of percentage of instruments Voting rights that can be acquired Subtotal B.1 B 2: Financial instruments / other instruments in accordance with Section 131 Paragraph 1 Z 2 BörseG 2018 Type of expiry date Exercise period Physical Number of percentage of instruments or cash Voting rights of settlement Voting rights Subtotal B.2 8. Information regarding the reportable person: ☒ The reportable person (point 3) is not controlled by a natural/legal person and does not control any other person who directly or indirectly holds instruments on the issuer. ☐ Full chain of controlled companies through which the voting rights and/or financial/other instruments are held, starting with the highest controlling natural or legal person: 9. In case of proxy, date of the general meeting: – Proportion of voting rights after the general meeting: – corresponds – Voting rights 10. Other comments: LLB Invest Kapitalanlagegesellschaft mbH holds the shares mentioned as a management company (KAG) of four investment funds. With regard to attribution/control, the exception applies according to Section 134 Paragraph 2 BörseG and Section 8 TransV 2018. Vienna on April 15, 2024 ═ ══════════════════════════════════════════════════ ══ 04/15/2024 CET/CEST ═════════════════════════════════ ═════════ ══════════════════════════════════ Language: German Company: Marinomed Biotech AG HoveGasse 25 2100 Korneuburg Austria Internet: www.marinomed.com
End of message EQS News Service 1880665 April 15, 2024 CET/CEST